19
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Molecular-docking study of capsular regulatory protein in Streptococcus pneumoniae portends the novel approach to its treatment

&
Pages 131-137 | Published online: 21 Dec 2011

References

  • Brooks WA, Breiman FR, Goswami D, et al. Invasive pneumococcal disease burden and implications for vaccine policy in urban Bangladesh. Am JTrop MedHyg. 2007;77(5):795–801.
  • World Health Organization (WHO). Causes of child mortality for the year 2008. Geneva: WHO; 2008. Available from: http://www.who.int/gho/child_health/mortality/mortality_causes_text/en/. Accessed April 04, 2011.
  • Saha SK, Rikitomi N, Biswas D, et al. Serotypes of Streptococcus pneumoniae causing invasive childhood infections in Bangladesh, 1992 to 1995. J Clin Microbiol. 1997;35(3):785–787.
  • Moschioni M, Pansegrau W, Barocchi MA. Adhesion determinants of the Streptococcus species. Microb Biotechnol. 2010;3(4):370–388.
  • Aspa J, Rajas O, Rodriguez de Castro F, et al. Drug-Resistant pneumococcal pneumonia: clinical relevance and related factors. Clin Infect Dis. 2004;38(6):787–798.
  • Watson DA, Musher DM. Interruption of capsule production in Streptococcus pneumoniae serotype 3 by insertion of transposon Tn916. Infect Immun. 1990;58(9):3135–3138.
  • Jiang S, Wang L, Reeves PR. Molecular characterization of Streptococcus pneumoniae type 4, 6B, 8, and 18C capsular polysaccharide gene clusters. Infect Immun. 2001;69(3):1244–1255.
  • Bender MH, Cartee RT, Yother J. Positive correlation between tyrosine phosphorylation of CpsD and capsular polysaccharide production in Streptococcus pneumoniae. JBacteriol. 2003;185(20):6057–6066.
  • Sali A, Potterton L, Yuan F, van Vlijmen H, Karplus M. Evaluation of comparative protein modelling by MODELLER. Proteins. 1995;23(3):318–326.
  • Altschul SF, Madden TL, Schaffer AA, et al. Gapped BLAST and PSI- BLAST: a new generation of protein database search programs. Nucleic Acids Res. 1997;25(17):3389–3402.
  • Bourne PE, Addess KJ, Bluhm WF, et al. The distribution and query systems of the RCSB Protein Data Bank. Nucleic Acids Res. 2004;32:D223-D225.
  • Larkin M, Blackshields G, Brown N, et al. Clustal W and Clustal X version 2.0. Bioinformatics. 2007;23(21):2947–2948.
  • Laskowski RA, MacArthur MW, Moss DS, Thornton JM. PROCHECK - a program to check the stereochemical quality of protein structures. JApp Cryst. 1993;26:283–291.
  • Luethy R, Bowie J, Eisenberg D. Assessment of protein models with three-dimensional profiles. Nature. 1992;356:83–85.
  • Colovos C, Yeates TO. Verification of protein structures: patterns of nonbonded atomic interactions. Protein Sci. 1993;2(9):1511–1519.
  • Maiti R, Van Domselaar GH, Zhang H, Wishart DS. SuperPose: a simple server for sophisticated structural superposition. Nucleic Acids Res. 2004;32:W590-W594.
  • Ramachandran GN, Ramakrishnan C, Sasisekharan V. Stereochemistry of polypeptide chain configurations. J Mol Biol. 1963;7:95–99.
  • Irwin JJ, Shoichet BK. ZINC - a free database of commercially available compounds for virtual screening. JChem Inf Model. 2005;45(1):177–182.
  • Morris GM, Huey R, Lindstrom W, et al. AutoDock4 and AutoDock- Tools4: automated docking with selective receptor flexibility. J Comput Chem. 2009;30(16):2785–2791.
  • Hagelueken G, Huang H, Mainprize IL, Whitfield C, Naismith JH. Crystal structures of Wzb of Escherichia coli and CpsB of Streptococcus pneumoniae, representatives of two families of tyrosine phosphatases that regulate capsule assembly. J Mol Biol. 2009;392:678–688. PDB ID: 2WJD.
  • Dundas J, Ouyang Z, Tseng J, Binkowski A, Turpaz Y, Liang J. CASTp: computed atlas of surface topography of proteins with structural and topographical mapping of functionally annotated residues. Nucleic Acids Res. 2006;34:W116-W118.
  • Brooijmans N, Kuntz ID. Molecular recognition and docking algorithms. Annu Rev Biophys Biomol Struct. 2003;32:335–373.
  • Alonsodevelasco E, Verheul AFM, Verhoef J, Snippe H. Streptococcus pneumoniae: virulence factors, pathogenesis, and vaccines. Microbiol Rev. 1995;59(4):591–603.
  • Morona JK, Morona R, Paton JC. Attachment of capsular polysaccharide to the cell wall of Streptococcus pneumoniae type 2 is required for invasive disease. Proc Natl Acad Sci. 2006;103(22):8505–8510.
  • Song JH, Jung SI, Ko KS, Kim NY, Son JS, Chang HH. High prevalence of antimicrobial resistant among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP Study). Antimicrob Agent Chemother. 2004;48:2101–2107.
  • Arnold K, Kiefer F, Kopp J, et al. The protein model portal. J Struct Funct Genomics. 2009;10(1):1–8.
  • Hillisch A, Pineda LF, Hilgenfeld R. Utility of homology models in the drug discovery process. Drug Discov Today. 2004;9(15):659–669.
  • Peitsch MC. About the use of protein models. BioinformaticsI. 2002;18:934–938.
  • Mulakayala C, Banaganapalli BN, Anuradha CM, Chitta SK. Insights from Streptococcus pneumoniae glucose kinase structural model. Bioinformation. 2009;3(7):308–310.
  • Brueggemann AB, Pai R, Crook DW, Beall B. Vaccine escape recombinants emerge after pneumococcal vaccination in the United States. PLoSPathog. 2007;3(11):e168.
  • Lynch JP 3rd, Zhanel GG. Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines. Curr Opin Pulm Med. 2010;16(3):217–225.
  • Jitendra S, Vinay R. Structure based drug designing of a novel antifla- viviral inhibitor for nonstructural 3 protein. Bioinformation. 2011 ;6(2): 57–60.
  • Brueggemann AB, Griffiths DT, Meats E, Peto T, Crook DW, Spratt BG. Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential. J Infect Dis. 2003;187(9):1424–1432.
  • Spratt BG, Greenwood BM. Prevention of pneumococcal disease by vaccination: does serotype replacement matter? Lancet. 2000;356(9237):1210–1211.